Trial reportAmerican journal of respiratory and critical care medicine2021
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
Abstract readClinical TrialMulticenter Study
In one paragraph
Trial report in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2022Guideline
- Diagnostic, prognostic, and therapeutic challenges in patients with hypersensitivity pneumonitis.ERJ open research · 2026Review
- Moving past multidisciplinary discussions and Gender-Age-Physiology model: precision medicine through biological phenotyping in interstitial lung disease.Current opinion in pulmonary medicine · 2025Review
- Global epidemiology and burden of interstitial lung disease.The Lancet. Respiratory medicine · 2025Review
- Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective.Respiratory research · 2025Review
- ITGAV, a specific biomarker associated with the pathogenesis of idiopathic pulmonary fibrosis.Scientific reports · 2025Article
- Progression of interstitial lung disease after the Envisia Genomic Classifier.ERJ open research · 2025Article
- Updates in Diagnostic Tools for ILD.Journal of clinical medicine · 2025Review
- Review
- Cost-effectiveness of novel diagnostic tools for idiopathic pulmonary fibrosis in the United States.BMC health services research · 2025Article
- Advances in idiopathic pulmonary fibrosis diagnosis and treatment.Chinese medical journal pulmonary and critical care medicine · 2025Review
- Spatially resolved gene expression profiles of fibrosing interstitial lung diseases.Scientific reports · 2024Article
- The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.American journal of respiratory and critical care medicine · 2024Article
- Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.American journal of respiratory and critical care medicine · 2024Review
- Employment of the Envisia Genomic Classifier in Conjunction With Cryobiopsy in Patients With Undiagnosed Interstitial Lung Disease.CHEST pulmonary · 2024Article
- Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.International journal of molecular sciences · 2024Review
- Article
- The efficacy and safety of radial endobronchial ultrasound-guided transbronchial lung cryobiopsy in the diagnosis of lung disease.Journal of thoracic disease · 2023Article
- Walking the path of treatable traits in interstitial lung diseases.Respiratory research · 2023Article
- Precision medicine advances in idiopathic pulmonary fibrosis.EBioMedicine · 2023Review
Corrections and comments
- Commented on by
Authors and funding
30 authors.
Luca RicheldiFondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Mary Beth ScholandDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
David A LynchDepartment of Radiology and.
Thomas V ColbyDivision of Pathology, National Jewish Health, Denver, Colorado.
Jeffrey L MyersDepartment of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, Arizona.
Steve D GroshongDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.
Jonathan H ChungDepartment of Radiology, University of Chicago, Chicago, Illinois.
Sadia BenzaquenDepartment of Medicine, Einstein Medical Center, Philadelphia, Pennsylvania.
Steven D NathanInova Heart and Vascular Institute, Inova Fairfax Hospital, Annandale, Virginia.
J Russell DavisDepartment of Surgery, St. Luke's Hospital, Chesterfield, Missouri.
Shelley L SchmidtDepartment of Medical Specialties, Spectrum Health Medical Group, Grand Rapids, Michigan.
Lars HagmeyerHospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.
David SonettiDepartment of Medicine, University of Wisconsin, Madison, Wisconsin.
Jurgen HetzelDepartment of Medicine, University Hospital Tuebingen, Tuebingen, Germany.
Gerard J CrinerDepartment of Thoracic Medicine and Surgery, Temple University, Philadelphia, Pennsylvania.
Amy H CasePulmonary, Critical Care, and Sleep Medicine, Piedmont Healthcare, Atlanta, Georgia.
Murali RamaswamyDepartment of Medicine, Pulmonix LLC, Greensboro, North Carolina.
Karel CaleroDepartment of Medicine, University of South Florida, Tampa, Florida.
Umair A GauharDepartment of Medicine, University of Louisville, Louisville, Kentucky.
Nina M PatelDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
Lisa LancasterDepartment of Medicine, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee.
Yoonha ChoiVeracyte, Inc., San Francisco, California.
Daniel G PankratzVeracyte, Inc., San Francisco, California.
P Sean WalshVeracyte, Inc., San Francisco, California.
Lori R LofaroVeracyte, Inc., San Francisco, California.
Jing HuangVeracyte, Inc., San Francisco, California.
Sangeeta M BhoradeVeracyte, Inc., San Francisco, California.
Giulia C KennedyVeracyte, Inc., San Francisco, California.
Fernando J MartinezDepartment of Medicine, Weill Cornell Medical College, New York, New York; and.
Ganesh RaghuDepartment of Medicine, University of Washington, Seattle, Washington.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Tomography, X-Ray ComputedAdultAgedAged, 80 and overFemaleGenetic MarkersGenomicsHumansIdiopathic Pulmonary FibrosisMaleMiddle AgedProspective StudiesReproducibility of ResultsSensitivity and SpecificityGenetic Markersidiopathic pulmonary fibrosismolecular classifierusual interstitial pneumonia
Identifiers
PMID
32721166What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.